EROL, C. Et Al. 2023. Comparison of Adjuvant Modified FOLFIRINOX with Other Adjuvant Chemotherapies in Resected Pancreatic Adenocarcinoma: Real-life Data. ACTA ONCOLOGICA TURCICA , vol.56, no.2 , 170-179.

EROL, C., HAFIZOĞLU, E., aykan, m. b., GÜVEN, D. C., Dursun, B., Hizal, M., ... kahraman, s.(2023). Comparison of Adjuvant Modified FOLFIRINOX with Other Adjuvant Chemotherapies in Resected Pancreatic Adenocarcinoma: Real-life Data. ACTA ONCOLOGICA TURCICA , vol.56, no.2, 170-179.

EROL, CİHAN Et Al. "Comparison of Adjuvant Modified FOLFIRINOX with Other Adjuvant Chemotherapies in Resected Pancreatic Adenocarcinoma: Real-life Data," ACTA ONCOLOGICA TURCICA , vol.56, no.2, 170-179, 2023

EROL, CİHAN Et Al. "Comparison of Adjuvant Modified FOLFIRINOX with Other Adjuvant Chemotherapies in Resected Pancreatic Adenocarcinoma: Real-life Data." ACTA ONCOLOGICA TURCICA , vol.56, no.2, pp.170-179, 2023

EROL, C. Et Al. (2023) . "Comparison of Adjuvant Modified FOLFIRINOX with Other Adjuvant Chemotherapies in Resected Pancreatic Adenocarcinoma: Real-life Data." ACTA ONCOLOGICA TURCICA , vol.56, no.2, pp.170-179.

@article{article, author={CİHAN EROL Et Al. }, title={Comparison of Adjuvant Modified FOLFIRINOX with Other Adjuvant Chemotherapies in Resected Pancreatic Adenocarcinoma: Real-life Data}, journal={ACTA ONCOLOGICA TURCICA}, year=2023, pages={170-179} }